4//SEC Filing
Zeng Ling 4
Accession 0000950170-24-013350
CIK 0001850838other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:56 PM ET
Size
5.5 KB
Accession
0000950170-24-013350
Insider Transaction Report
Form 4
Zeng Ling
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-02-07+125,000→ 125,000 totalExercise: $3.59Exp: 2034-02-06→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001824252
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:56 PM ET
- Size
- 5.5 KB